These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9824585)

  • 1. Frequency of replication errors in colorectal cancer and their association with family history.
    Brown SR; Finan PJ; Cawkwell L; Quirke P; Bishop DT
    Gut; 1998 Oct; 43(4):553-7. PubMed ID: 9824585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite instability in early onset and familial colorectal cancer.
    Brassett C; Joyce JA; Froggatt NJ; Williams G; Furniss D; Walsh S; Miller R; Evans DG; Maher ER
    J Med Genet; 1996 Dec; 33(12):981-5. PubMed ID: 9004127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients.
    Aaltonen LA; Peltomäki P; Mecklin JP; Järvinen H; Jass JR; Green JS; Lynch HT; Watson P; Tallqvist G; Juhola M
    Cancer Res; 1994 Apr; 54(7):1645-8. PubMed ID: 8137274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.
    Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D
    JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of the Amsterdam criteria in a regional German cohort of patients with colorectal cancer.
    Raedle J; Schaffner M; Esser N; Sahm S; Trojan J; Kriener S; Brieger A; Nier H; Bockhorn H; Berg PL; Frick B; Schäfer D; Zeuzem S
    Z Gastroenterol; 2002 Aug; 40(8):561-8. PubMed ID: 12297979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors.
    Senba S; Konishi F; Okamoto T; Kashiwagi H; Kanazawa K; Miyaki M; Konishi M; Tsukamoto T
    Cancer; 1998 Jan; 82(2):279-85. PubMed ID: 9445183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
    Kravochuck SE; Church JM
    ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
    de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L
    Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary non-polyposis colorectal cancer (HNPCC): new germline mutation (190-191 del AA) in the human MLH1 gene and review of clinical guidelines for surveillance of affected families.
    Schiemann U; Papatheodorou L; Glasl S; Gross M
    Eur J Med Res; 2001 Mar; 6(3):93-100. PubMed ID: 11309221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal neoplasms detected colonoscopically in at-risk members of colorectal cancer families stratified by the demonstration of DNA microsatellite instability.
    Jass JR; Pokos V; Arnold JL; Cottier DS; Jeevaratnam P; Van de Water NS; Browett PJ; Winship IM; Lane MR
    J Mol Med (Berl); 1996 Sep; 74(9):547-51. PubMed ID: 8892060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary non-polyposis colorectal cancer (HNPCC): phenotype-genotype correlation between patients with and without identified mutation.
    Bisgaard ML; Jäger AC; Myrhøj T; Bernstein I; Nielsen FC
    Hum Mutat; 2002 Jul; 20(1):20-7. PubMed ID: 12112654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds.
    Nakahara M; Yokozaki H; Yasui W; Dohi K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1057-64. PubMed ID: 9419403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer.
    Jass JR; Cottier DS; Jeevaratnam P; Pokos V; Holdaway KM; Bowden ML; Van de Water NS; Browett PJ
    Lancet; 1995 Nov; 346(8984):1200-1. PubMed ID: 7475662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical phenotype of Chinese hereditary nonpolyposis colorectal cancer (HNPCC) families].
    Yuan Y; Cao WM; Cai SR; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):36-8. PubMed ID: 16737618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
    Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
    J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
    Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
    Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.
    Irmejs A; Borosenko V; Melbarde-Gorkusa I; Gardovskis A; Bitina M; Kurzawski G; Suchy J; Gorski B; Gardovskis J
    Anticancer Res; 2007; 27(1B):653-8. PubMed ID: 17348456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.